Suppr超能文献

替加环素治疗期间获得假单胞菌属和变形杆菌属的危险因素的病例对照研究。

Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy.

作者信息

Park Ga Eun, Kang Cheol-In, Wi Yu Mi, Ko Jae-Hoon, Lee Woo Joo, Lee Ji Yong, Cho Sun Young, Ha Young Eun, Chung Doo Ryeon, Peck Kyong Ran, Song Jae-Hoon

机构信息

Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

出版信息

Antimicrob Agents Chemother. 2015 Sep;59(9):5830-3. doi: 10.1128/AAC.04865-14. Epub 2015 Jun 22.

DOI:10.1128/AAC.04865-14
PMID:26100705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4538539/
Abstract

Tigecycline is an important agent in clinical practice because of its broad-spectrum activity. However, it has no activity against Pseudomonas or Proteus species. We conducted a case-control study to analyze risk factors for the acquisition of Pseudomonas or Proteus spp. during tigecycline therapy. Placement of suction drainage at infected wound sites, ICU stay, and neurologic disease were identified as independent risk factors for the acquisition of Pseudomonas and Proteus spp.

摘要

替加环素因其广谱活性而成为临床实践中的一种重要药物。然而，它对假单胞菌属或变形杆菌属无活性。我们进行了一项病例对照研究，以分析替加环素治疗期间获得假单胞菌属或变形杆菌属的危险因素。在感染伤口部位放置吸引引流、入住重症监护病房（ICU）和神经系统疾病被确定为获得假单胞菌属和变形杆菌属的独立危险因素。

相似文献

1
Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy.替加环素治疗期间获得假单胞菌属和变形杆菌属的危险因素的病例对照研究。
Antimicrob Agents Chemother. 2015 Sep;59(9):5830-3. doi: 10.1128/AAC.04865-14. Epub 2015 Jun 22.
2
Tigecycline: a critical update.替加环素：重要更新
J Chemother. 2008 Aug;20(4):411-9. doi: 10.1179/joc.2008.20.4.411.
3
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.针对重症监护病房住院患者的医院内细菌病原体测试替加环素的抗菌活性。
Diagn Microbiol Infect Dis. 2005 Jul;52(3):203-8. doi: 10.1016/j.diagmicrobio.2005.05.002.
4
Tigecycline.替加环素
J Antimicrob Chemother. 2005 Sep;56(3):470-80. doi: 10.1093/jac/dki248. Epub 2005 Jul 22.
5
Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections.替加环素在患有严重医院获得性腹腔内感染的重症患者中的应用。
Rev Esp Quimioter. 2013 Mar;26(1):56-63.
6
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.替加环素与其他抗菌药物联合应用：体外、动物及病例报告研究综述
Int J Antimicrob Agents. 2009 Jul;34(1):8.e1-9. doi: 10.1016/j.ijantimicag.2008.11.006. Epub 2009 Jan 21.
7
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.针对引起社区获得性呼吸道感染和医院获得性肺炎的病原体测试替加环素的抗菌活性。
Diagn Microbiol Infect Dis. 2005 Jul;52(3):187-93. doi: 10.1016/j.diagmicrobio.2005.05.004.
8
Increasing frequency of Pseudomonas aeruginosa infections during tigecycline use.使用替加环素期间铜绿假单胞菌感染频率增加。
J Infect Dev Ctries. 2015 Mar 15;9(3):309-12. doi: 10.3855/jidc.4700.
9
[Perspectives of tigecycline treatment of surgical site infections in oncologic patients].[替加环素治疗肿瘤患者手术部位感染的前景]
Antibiot Khimioter. 2012;57(3-4):33-9.
10
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).针对2000 - 2004年与皮肤及软组织感染相关的国际细菌病原体集合测试替加环素的效力和抗菌谱。
Diagn Microbiol Infect Dis. 2005 Jul;52(3):195-201. doi: 10.1016/j.diagmicrobio.2005.05.003.

本文引用的文献

1
Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review.替加环素治疗多重耐药革兰阴性杆菌所致尿路感染的系统评价
J Antimicrob Chemother. 2014 Oct;69(10):2606-10. doi: 10.1093/jac/dku189. Epub 2014 May 30.
2
The Effect of Vacuum-Assisted Closure on the Bacterial Load and Type of Bacteria: A Systematic Review.负压封闭引流对细菌载量及细菌类型的影响：一项系统评价
Adv Wound Care (New Rochelle). 2014 May 1;3(5):383-389. doi: 10.1089/wound.2013.0510.
3
Does the application of incisional negative pressure therapy to high-risk wounds prevent surgical site complications? A systematic review.对高危伤口应用切口负压疗法能否预防手术部位并发症？一项系统评价。
Eplasty. 2013 Sep 20;13:e49. eCollection 2013.
4
Negative pressure therapy for high-risk abdominal wall reconstruction incisions.负压治疗高危腹壁重建切口。
Surg Infect (Larchmt). 2013 Jun;14(3):270-4. doi: 10.1089/sur.2012.059. Epub 2013 Apr 16.
5
Use of negative pressure wound therapy over clean, closed surgical incisions.使用负压伤口疗法处理清洁、闭合的手术切口。
Int Wound J. 2012 Aug;9 Suppl 1(Suppl 1):32-9. doi: 10.1111/j.1742-481X.2012.01017.x.
6
An innovative technique for intra-abdominal abscess drainage using a sump drain by trocar puncture.
Am Surg. 2011 Aug;77(8):E166-7.
7
Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage.微生物分离和与替加环素使用相关的抗菌药物耐药性的出现。
J Microbiol Immunol Infect. 2011 Oct;44(5):352-7. doi: 10.1016/j.jmii.2011.01.033. Epub 2011 Jan 20.
8
Superinfection during treatment of nosocomial infections with tigecycline.治疗医院获得性感染时的继发感染。
Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):867-71. doi: 10.1007/s10096-010-0942-y. Epub 2010 May 16.
9
Management of complicated infections in the era of antimicrobial resistance: the role of tigecycline.抗菌药物耐药时代复杂感染的管理：替加环素的作用
Expert Opin Pharmacother. 2009 May;10(7):1213-22. doi: 10.1517/14656560902900853.
10
Tigecycline.替加环素
J Postgrad Med. 2009 Jan-Mar;55(1):65-8. doi: 10.4103/0022-3859.48443.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验